作者 Zeng, Ke-Wu; Yu, Qian; Song, Fang-Jiao; Liao, Li-Xi; Zhao, Ming-Bo; Dong, Xin; Jiang, Yong; Tu, Peng-Fei
期刊 EUROPEAN JOURNAL OF PHARMACOLOGY , FEB 5 2015,:748
DOI 10.1016/j.ejphar.2014.12.013 PubMed 25530267
摘要 Caesalpinia sappan L. (Lignum Sappan) is a Chinese medicinal plant for treating ischemic cerebral apoplexy. Deoxysappanone B (DSB), a homoisoflavone compound isolated from C. sappan L. (Lignum Sappan), was studied for anti-neuroinflammatory and neuroprotective properties using lipopolysaccharide (LPS)-induced BV-2 microglia neuroinflammation model and LPS-induced microglia-neuron co-culture system. Our findings showed that DSB effectively inhibited BV-2 microglia-mediated neuroinflammatory mediators'' release including NO, PGE(2), TNE-alpha, IL-G and reactive oxygen species. Moreover, DSB markedly protected neurons against inflammatory microglia-mediated neurotoxicity in a microglia-neuron co-culture system. Mechanism study revealed that DSB blocked two major neuroinflammation related signaling pathways including IKK-I kappa B-nuclear factor kappaB (NE-kappa B) and p38/ERK mitogen-activated protein kinase (MAPK) cascades, further leading to the inhibition of neuroinflammatory mediators'' production. The present study provides evidence that the anti-neuroinflammatory and neuroprotective effect of DSB are clue to the suppression of neuroinflammatory mediators'' production as well as inflammation-induced neurotoxicity through regulation of multi-targets. Therefore, DSB may serve as a neuroprotective agent for the treatment of neuroinflammatory disorders and inflammation related neuronal injury. (C) 2014 Elsevier B.V. All rights reserved.
版权所有 Copyright © 2002-2025 中国科学院昆明植物研究所,All Rights Reserved 【滇ICP备05000394号】
地址:中国云南省昆明市蓝黑路132号 邮政编码:650201 点击这里联系我们